Imara Boston 2
Pharma & Biotech company headquartered in Boston, MA. Cross-border supply chain, facility locations, and freight intelligence below.
Imara Inc. was a clinical-stage biopharmaceutical company founded in 2016 that merged with Enliven Therapeutics in February 2023, with the combined entity operating under the Enliven name. Enliven focuses on the discovery and development of next-generation small molecule kinase inhibitors for cancer treatment. The company is a small, research-driven biotech with 11-50 employees and no physical manufacturing operations.
- Industry
- Pharma & Biotech
- Headquarters
- Boston, MA
- Revenue
- $165 million
- US facilities
- Boston, MA
Start a free trial to see Imara Boston 2’s full freight profile — facility network, cross-border lanes, and shipper intelligence.